Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR

Escaned, J., Cao, D., Baber, U., Nicolas, J., Sartori, S., Zhang, Z., Dangas, G., Angiolillo, D. J., Briguori, C., Cohen, D. J., Collier, T., Dudek, D., Gibson, M., Gil, R., Huber, K., Kaul, U., Kornowski, R., Krucoff, M. W., Kunadian, V., … Mehran, R. (2021). Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR. European Heart Journal, 42(45), 4624–4634. https://doi.org/10.1093/eurheartj/ehab702
Authors:
Javier Escaned
Davide Cao
Usman Baber
Johny Nicolas
Samantha Sartori
Zhongjie Zhang
George Dangas
Dominick J Angiolillo
Carlo Briguori
David J Cohen
Timothy Collier
Dariusz Dudek
Michael Gibson
Robert Gil
Kurt Huber
Upendra Kaul
Ran Kornowski
Mitchell W Krucoff
Vijay Kunadian
Shamir Mehta
David J Moliterno
E Magnus Ohman
Keith G Oldroyd
Gennaro Sardella
Samin K Sharma
Richard Shlofmitz
Giora Weisz
Bernhard Witzenbichler
Stuart Pocock
Roxana Mehran
Affiliated Authors:
Giora Weisz
Columbia Affiliation:
Author Keywords:
arc-hbr
aspirin
high bleeding risk
pci
ticagrelor monotherapy
elink
Publication Type:
Article
Unique ID:
10.1093/eurheartj/ehab702
PMID:
34662382
DOI:
10.1093/eurheartj/ehab702
Journal:
European Heart Journal
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record

Record Created: